The relationship between RRM1 gene polymorphisms and effectiveness of gemcitabine-based first-line chemotherapy in advanced NSCLC patient

PURPOSE: Chemotherapy with platinum compounds and gemcitabine is frequently used in first-line treatment of advanced non-small cell lung cancer (NSCLC) patients in which tyrosine kinase inhibitors (EGFR or ALK) cannot be administered. Unfortunately, less than half of the patients achieve the benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mlak, R., Krawczyk, P., Ciesielka, M., Kozioł, P., Homa, I., Powrózek, T., Prendecka, M., Milanowski, J., Małecka-Massalska, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995236/
https://www.ncbi.nlm.nih.gov/pubmed/26650486
http://dx.doi.org/10.1007/s12094-015-1461-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995236/
https://www.ncbi.nlm.nih.gov/pubmed/26650486
http://dx.doi.org/10.1007/s12094-015-1461-1

Ejemplares similares